Qianjiang Yongan Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 002365.SZ

Qianjiang Yongan Pharmaceutical Co., Ltd. Net Income for the year ending December 31, 2023: USD -1.73 M

Qianjiang Yongan Pharmaceutical Co., Ltd. Net Income is USD -1.73 M for the year ending December 31, 2023, a -108.53% change year over year. Net income is the total profit earned by a company after deducting all expenses, including taxes and non-controlling interest.

Qianjiang Yongan Pharmaceutical Co., Ltd. Net Income for the year ending December 31, 2022 was USD 20.34 M, a 15.99% change year over year.
Qianjiang Yongan Pharmaceutical Co., Ltd. Net Income for the year ending December 31, 2021 was USD 17.53 M, a 8.43% change year over year.
Qianjiang Yongan Pharmaceutical Co., Ltd. Net Income for the year ending December 31, 2020 was USD 16.17 M, a 25.22% change year over year.
Qianjiang Yongan Pharmaceutical Co., Ltd. Net Income for the year ending December 31, 2019 was USD 12.91 M, a -50.27% change year over year.

Key data

Date	Net Income	EPS (Diluted)	Shares (Diluted, Weighted)	Net Income Margin

Shenzhen Stock Exchange: 002365.SZ

Qianjiang Yongan Pharmaceutical Co., Ltd.

CEO	Mr. Rengui Hong
IPO Date	March 5, 2010
Location	China
Headquarters	No. 2 Guangze Avenue
Employees	887
Sector	Industrials
Industries Petrochemicals Cleaning Supplies Fertilizers Glass Non-Alcoholic Beverages Personal Care Pet Food Soft Drinks & Sodas